Bill Ackman's Insider Trading Lawsuit May Cost Pershing Square Investors $75 Million |
| March 30, 2017 | March 2017 Bond Updates |
|
Pershing Square is setting aside $75 million to cover a class action insider trading lawsuit surrounding its efforts to merge Allergan with now-embattled Valeant, which made Bill Ackman $1.1 billion according to Forbes. |
| View more at: http://www.forbes.com/sites/antoinegara/2017/03/29/bill-ackmans-insider-trading-lawsuit-may-cost-pershing-square-investors-75-million/ |
| Related News |